nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.06.2008 | Original Paper

Kaposi’s sarcoma after liver transplantation

verfasst von: Fabrizio Di Benedetto, Stefano Di Sandro, Nicola De Ruvo, Massimiliano Berretta, Michele Masetti, Roberto Montalti, Roberto Ballarin, Stefania Cocchi, Leonardo Potenza, Mario Luppi, Giorgio E. Gerunda

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Kaposi’s Sarcoma (KS) is a malignant neoplasm arising from endothelial cells. HHV8-infection represents a key pathogenic determinant for the development of KS. There are no standard criteria to treat KS in immunosuppressed-individuals. Six cases (2.1%) of KS occurred in our Center among 285-recipients who underwent liver transplantation (LT) between October 2000 and November 2006.

Methods

Patients were four males and two females. Mean age was 57 years (range 44–65). Indication for LT was ESLD associated/non-associated with hepatocellular carcinoma (HCC). The immunosuppressive regimen consisted of cyclosporine/tacrolimus associated with steroids or daclizumab. HHV8-detection was performed by the serological method before LT, and by polymerase chain reaction (PCR)-analysis after KS.

Results

One patient had HCV-related cirrhosis and coinfection from HIV, three had HBV-related cirrhosis, two of these with coexistent HCC. The last two patients had alcoholic-cirrhosis, one with coexistent HCC. Mean time from transplantation to KS was 6.2 months (range 3.8–8.8). Three patients were treated with doxorubicin and three with switch from calcineurin-inhibitors to sirolimus. Three patients expired after 11.5, 8.8, and 7.4 months from KS diagnosis.

Discussion

KS should be treated by a multidisciplinary approach to obtain an early diagnosis and best management. Effective treatment with immunosuppression reduction or switch to sirolimus is mandatory and can induce complete regression.

Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, Angelico M, Leone P, Citterio F, Ensoli B, Rezza G (2001) Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi’s sarcoma in renal and liver transplant recipients. J Infect 43(3):195–199PubMedCrossRef

Antman K, Chang Y (2000) Kaposi’s sarcoma. N Engl J Med 342(14):1027–1038 (review)PubMedCrossRef

Aseni P, Vertemati M, Minola E, Arcieri K, Bonacina E, Camozzi M, Osio C, Forti D (2001) Kaposi’s sarcoma in liver transplant recipients: morphological and clinical description. Liver Transpl 7(9):816–823PubMedCrossRef

Boeckle E, Boesmueller C, Wiesmayr S, Mark W, Rieger M, Tabarelli D, Graziadei I, Hoefer D, Antretter H, Stelzmueller I, Krugmann J, Zangerle R, Huemer H, Poelzl G, Margreiter R, Bonatti H (2005) Kaposi sarcoma in solid organ transplant recipients: a single center report. Transplant Proc 37(4):1905–1909PubMedCrossRef

Brenner B, Rakowsky E, Katz A, Gutman H, Sulkes A, Schacter J, Fenig E (1999) Tailoring treatment for classical Kaposi’s sarcoma: comprehensive clinical guidelines. Int J Oncol 14(6):1097–1102PubMed

Calabro ML, Sheldon J, Favero A, Simpson GR, Fiore JR, Gomes E, Angarano G, Chieco-Bianchi L, Schulz TF (1998) Seroprevalence of Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol 1(3):207–213PubMed

Chan JKC (1997) Vascular tumors with a prominent spindle cell component. Curr Diagn Pathol 4:76–90CrossRef

Franceschi S, Rezza G, Serraino D, Cozzi Lepri A, Geddes M, Cote T (1995) Risk for Kaposi’s sarcoma among Italian women with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 9(3):313–314PubMedCrossRef

Friborg J Jr, Kong W, Hottiger MO, Nabel GJ (1999) p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402(6764):889–894PubMed

Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 2(8):925–928PubMedCrossRef

Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8(2):128–135PubMedCrossRef

Gutierrez-Dalmau A, Campistol JM (2005) Kaposi’s sarcoma after renal transplantation. N Engl J Med 353(8):846–847 (author reply 846–847)

Jayachandra S, Low KG, Thlick AE, Yu J, Ling PD, Chang Y, Moore PS (1999) Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc Natl Acad Sci USA 96(20):11566–11571PubMedCrossRef

Klein E, Schwartz RA, Laor Y, Milgrom H, Burgess GH, Holtermann OA (1980) Treatment of Kaposi’s sarcoma with vinblastine. Cancer 45(3):427–431PubMedCrossRef

Lebbe C, Euvrard S, Barrou B, Pouteil-Noble C, Garnier JL, Glotz D, Legendre C, Frances C (2006) Sirolimus conversion for patients with posttransplant Kaposi’s sarcoma. Am J Transplant 6(9):2164–2168 (Epub 2006 Jun 19)PubMedCrossRef

Lesnoni La Parola I, Masini C, Nanni G, Diociaiuti A, Panocchia N, Cerimele D (1997) Kaposi’s sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988–1996. Dermatology 194(3):229–233PubMedCrossRef

London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP (1995) Risk of neoplasia in renal transplant patients. Lancet 12: 346(8972):403–446 (Erratum in Lancet 346(8976):714)

Margolius L, Stein M, Spencer D, Bezwoda WR (1994) Kaposi’s sarcoma in renal transplant recipients. Experience at Johannesburg Hospital, 1966–1989. S Afr Med J 84(1):16–17PubMed

Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH (1998) Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338(14):948–954PubMedCrossRef

Moore PS, Gao SJ, Dominguez G, Cesarman E, Lungu O, Knowles DM, Garber R, Pellett PE, McGeoch DJ, Chang Y (1996) Primary characterization of a herpesvirus agent associated with Kaposi’s sarcoma. J Virol 70(1):549–558. Erratum in J Virol 70(12):9083

Nickoloff BJ, Griffiths CE (1989) The spindle-shaped cells in cutaneous Kaposi’s sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes. Am J Pathol 135(5):793–800PubMed

Penn I (1990) Cancers complicating organ transplantation. N Engl J Med 323(25):1767–1769PubMedCrossRef

Penn I (1995) Sarcomas in organ allograft recipients. Transplantation 60(12):1485–91 (review)PubMed

Reynolds WA, Winkelmann RK, Soule EH (1965) Kaposi’s sarcoma: a clinicopathologic study with particular reference to its relationship to the reticuloendothelial system. Medicine (Baltimore) 44(5):419–443 (review)CrossRef

Shepherd FA, Maher E, Cardella C, Cole E, Greig P, Wade JA, Levy G (1997) Treatment of Kaposi’s sarcoma after solid organ transplantation. J Clin Oncol 15(6):2371–2377PubMed

Shiffman ML, Saab S, Feng S, Abecassis MI, Tzakis AG, Goodrich NP, Schaubel DE (2006) Liver and intestine transplantation in the United States, 1995–2004. Am J Transplant 6(5 Pt 2):1170–1187PubMedCrossRef

Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G (2005) Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 352(13):1317–1323PubMedCrossRef

Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Bishoff C, Hatzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, Schultz TF (1995) Detection of Kaposi’s sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 346:799–802PubMedCrossRef

Titel: Kaposi’s sarcoma after liver transplantation
verfasst von: Fabrizio Di Benedetto
Stefano Di Sandro
Nicola De Ruvo
Massimiliano Berretta
Michele Masetti
Roberto Montalti
Roberto Ballarin
Stefania Cocchi
Leonardo Potenza
Mario Luppi
Giorgio E. Gerunda
Publikationsdatum: 01.06.2008
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2008
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-007-0329-3

Springer Medizin

Kaposi’s sarcoma after liver transplantation